Page 121 - OR-1-2
P. 121

ORIGINAL RESEARCH ARTICLE
            A trabeculae-like biomimetic bone-filling material

            as a potential organoid for bone defect treatment



            Fanjin Meng , Yang Yu , Jinshu Yu , Hong Chen , Yuwen Ma , Yonghao Chen , Yan Wang , Jingjing Jiang ,
                                                                               2
                                                                 2
                                                                                                       2
                                                                                         2
                                                      2
                                 3
                       1,2
                                           2
            Xi He , Zhongyan Zhan , Pingping Yan , Jing Wen , Lijuan Zhang , Wei Chen , Airong Qian 5  , Xiaolan Guo ,
                 2
                                                                     1
                                                                              4
                                              2
                                                                                                         1,2
                                                       1
                                 2
            Bing Yang *, Qi Liang *, Guangrong Wang *, Bin Guo *, Chong Yin *
                     6
                               1,2
                                                                         1,2
                                                  1,2
                                                             1,2
            1 Department of Clinical Laboratory, Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan,
            China
            2 School of Laboratory Medicine, Translational Medicine Research Center, North Sichuan Medical College, Nanchong, Sichuan, China
            3 School of Pharmacy, Tianjin Medical University, Tianjin, China
            4 Xinjiang Huashidan Pharmaceutical Research Co., Ltd., Urumqi, Xinjiang Uygur Autonomous Region, China
            5 Lab for Bone Metabolism, Xi’an Key Laboratory of Special Medicine and Health Engineering, Key Lab for Space Biosciences
            and Biotechnology, Research Center for Special Medicine and Health Systems Engineering, NPU-UAB Joint Laboratory for Bone
            Metabolism, School of Life Sciences, Northwestern Polytechnical University, 127 West Youyi Road, Xi’an, Shaanxi, China
            6 Department of Public Health, International School, Krirk University, Bangkok, Thailand
            *Corresponding authors: Bing Yang (yang.bing@krirk.ac.th); Qi Liang (liangqineijiang@126.com);
            Guangrong Wang (13699669835@163.com); Bin Guo (guobin@nsmc.edu.cn); Chong Yin (yinchong42@nsmc.edu.cn)
            Citation: Meng F, Yu Y, Yu J, et al.   Abstract
            A trabeculae-like biomimetic bone-
            filling material as a potential organoid   Bone-filling materials are critical tools for the treatment of bone defects. However,
            for bone defect treatment. Organoid
            Res. 2025;1(2):025040003.     existing materials require improvements in tissue compatibility and drug-loading
            doi: 10.36922/OR025040003     capacity. In this study, we designed and synthesized a novel trabeculae-like biomimetic
            Received: September 30, 2024  bone-filling material (TBM) that mimics the composition and structure of natural
                                          bone trabecular tissue. This TBM demonstrated high mechanical strength and
            Revised: February 19, 2025
                                          excellent biocompatibility. It effectively embedded osteogenic cells and potentially
            Accepted: March 14, 2025      functioned as an organoid. We demonstrated that the TBM exhibited therapeutic
            Published online: April 18, 2025  efficacy in treating various bone defects and fractures by filling defect regions and
                                          enabling sustained release of small-molecule and nucleic acid drugs. Based on these
            Copyright: © 2025 Author(s).
            This is an Open-Access article   findings, we propose TBM as a promising candidate for the treatment of bone defects
            distributed under the terms of the   and provide innovative insights for the development of bone-filling materials.
            Creative Commons Attribution
            License, permitting distribution, and
            reproduction in any medium, which   Keywords: Bone-filling material; Organoid; Bone defect; Tissue engineering
            provided that the original work is
            properly cited.
            Publisher’s Note: AccScience
            Publishing remains neutral with regard
            to jurisdictional claims in published
            maps and institutional affiliations.
            1. Introduction                                   treatment costs, severely impairing patients’ quality of life.
                                                                                                            5
                                                              Consequently, the accurate and efficient treatment of bone
            Bone defects can arise from fractures and various bone   defects remains a major challenge in orthopedic research.
            diseases, including bone tumors and osteomyelitis.
                                                          1,2
            Critical-sized bone defects, in particular, cannot self-heal   Bone-filling materials are essential tools for addressing
            through intrinsic repair mechanisms.  These defects   bone defects, as they fill defect regions, provide mechanical
                                             3,4
                                                                                             6-8
            are  characterized  by  prolonged  rehabilitation  periods,   support, and promote bone formation.  While autologous
            high disability rates, and significant post-operative   or allogeneic bone transplantation is considered the optimal


            Volume 1 Issue 2 (2025)                         1                            doi: 10.36922/OR025040003
   116   117   118   119   120   121   122   123   124   125   126